drugset / Trial / NCT00972907

An Open Label Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing in Human Subjects

NCT00972907

Phase 1/2 Completed 20 enrolled RDD Pharma Ltd
NaSingle-groupOpen-labelTreatment

Summary

This is an open label study. The study will consist of 1 treatment group: coated Nifedipine suppository containing 12 mg of Nifedipine, administered BID to subjects with chronic anal fissure.

Timeline

Start
2009-12
Primary completion
2011-01
Completion
2011-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Nifedipine Other / unclassified 12 mg Rectal